A GlobeNewswire release forecasts the GLP-1 drug market topping $132 billion within the next decade. Details beyond the headline figure are thin.
Recap by typeshit. Full story at GlobeNewswire.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
The Dermatology Digest covers a study pairing the psoriasis biologic with tirzepatide, reporting bigger biomarker shifts from the combination.
A personal week two check-in from someone documenting their tirzepatide journey, with 2 pounds lost in the latest week.
Loading…